Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP593862.RA2ewiGrb9OFUjA2i_k9HL43dWY4HfBiGaQV6QD3iElo8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP593862.RA2ewiGrb9OFUjA2i_k9HL43dWY4HfBiGaQV6QD3iElo8130_assertion type Assertion NP593862.RA2ewiGrb9OFUjA2i_k9HL43dWY4HfBiGaQV6QD3iElo8130_head.
- NP593862.RA2ewiGrb9OFUjA2i_k9HL43dWY4HfBiGaQV6QD3iElo8130_assertion description "[Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593862.RA2ewiGrb9OFUjA2i_k9HL43dWY4HfBiGaQV6QD3iElo8130_provenance.
- NP593862.RA2ewiGrb9OFUjA2i_k9HL43dWY4HfBiGaQV6QD3iElo8130_assertion evidence source_evidence_literature NP593862.RA2ewiGrb9OFUjA2i_k9HL43dWY4HfBiGaQV6QD3iElo8130_provenance.
- NP593862.RA2ewiGrb9OFUjA2i_k9HL43dWY4HfBiGaQV6QD3iElo8130_assertion SIO_000772 17299092 NP593862.RA2ewiGrb9OFUjA2i_k9HL43dWY4HfBiGaQV6QD3iElo8130_provenance.
- NP593862.RA2ewiGrb9OFUjA2i_k9HL43dWY4HfBiGaQV6QD3iElo8130_assertion wasDerivedFrom befree-2016 NP593862.RA2ewiGrb9OFUjA2i_k9HL43dWY4HfBiGaQV6QD3iElo8130_provenance.
- NP593862.RA2ewiGrb9OFUjA2i_k9HL43dWY4HfBiGaQV6QD3iElo8130_assertion wasGeneratedBy ECO_0000203 NP593862.RA2ewiGrb9OFUjA2i_k9HL43dWY4HfBiGaQV6QD3iElo8130_provenance.